A Beta-catenin/TCF-coordinated Chromatin Loop at MYC Integrates 5' and 3' Wnt Responsive Enhancers

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2009 Dec 8

PMID 19966299

Citations 56

Authors

Gregory S Yochum

Colette M Sherrick

Mary Macpartlin

Richard H Goodman

Affiliations

Soon will be listed here.

Abstract

Aberrant MYC gene expression by the Wnt/beta-catenin pathway is implicated in colorectal carcinogenesis. Wnt/beta-catenin signaling stimulates association of the beta-catenin coactivator complex with two Wnt responsive enhancers (WREs) located in close proximity to MYC gene boundaries. Each enhancer directly binds members of the TCF/Lef family of transcription factors that, in turn, recruit beta-catenin. In a previous report, we showed that the downstream MYC enhancer (MYC 3' WRE) cooperated with the upstream enhancer (MYC 5' WRE) to activate expression of a heterologous reporter gene in response to Wnt/beta-catenin and mitogen signaling. Here we use chromatin conformation capture (3C) to show that the MYC 5' and 3' WREs are juxtaposed at the genomic MYC locus during active transcription. This MYC 5'3' chromatin loop is present in HCT116 human colorectal cancer cells that contain high levels of nuclear beta-catenin and is absent in HEK293 cells that contain trace amounts of nuclear beta-catenin. Depletion of functional beta-catenin/TCF complexes blocks formation of the MYC 5'3 chromatin loop. Furthermore, we find that the chromatin loop is absent in quiescent cells, but is rapidly and transiently induced by serum mitogens in a beta-catenin-dependent manner. Thus, we propose that a distinct chromatin architecture coordinated by beta-catenin/TCF-bound WREs accompanies transcriptional activation of MYC gene expression.

Citing Articles

KLF6-mediated recruitment of the p300 complex enhances H3K23su and cooperatively upregulates SEMA3C with FOSL2 to drive 5-FU resistance in colon cancer cells.

Zhang B, Qi T, Lin J, Zhai S, Wang X, Zhou L Exp Mol Med. 2025; .

PMID: 40082673 DOI: 10.1038/s12276-025-01424-1.

Menin in Cancer.

Majer A, Hua X, Katona B Genes (Basel). 2024; 15(9).

PMID: 39336822 PMC: 11431421. DOI: 10.3390/genes15091231.

Chromatin and DNA Dynamics in Mouse Models of Liver Cancers.

Sanceau J, Forne T, Chantalat S, Gougelet A Methods Mol Biol. 2024; 2769:167-187.

PMID: 38315397 DOI: 10.1007/978-1-0716-3694-7_13.

DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.

Sanceau J, Poupel L, Joubel C, Lagoutte I, Caruso S, Pinto S Mol Ther. 2024; 32(4):1125-1143.

PMID: 38311851 PMC: 11163201. DOI: 10.1016/j.ymthe.2024.01.036.

Visinin-like 1, a novel target gene of the Wnt/β-catenin signaling pathway, is involved in apoptosis resistance in colorectal cancer.

Tage H, Yamaguchi K, Nakagawa S, Kasuga S, Takane K, Furukawa Y Cancer Med. 2023; 12(12):13426-13437.

PMID: 37096864 PMC: 10315817. DOI: 10.1002/cam4.5970.

References

Hadjur S, Williams L, Ryan N, Cobb B, Sexton T, Fraser P . Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. Nature. 2009; 460(7253):410-3. PMC: 2869028. DOI: 10.1038/nature08079. View

Yochum G, Cleland R, Goodman R . A genome-wide screen for beta-catenin binding sites identifies a downstream enhancer element that controls c-Myc gene expression. Mol Cell Biol. 2008; 28(24):7368-79. PMC: 2593444. DOI: 10.1128/MCB.00744-08. View

POY F, Lepourcelet M, Shivdasani R, Eck M . Structure of a human Tcf4-beta-catenin complex. Nat Struct Biol. 2001; 8(12):1053-7. DOI: 10.1038/nsb720. View

Yochum G, McWeeney S, Rajaraman V, Cleland R, Peters S, Goodman R . Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells. Proc Natl Acad Sci U S A. 2007; 104(9):3324-9. PMC: 1805576. DOI: 10.1073/pnas.0611576104. View

Tolhuis B, Palstra R, Splinter E, Grosveld F, de Laat W . Looping and interaction between hypersensitive sites in the active beta-globin locus. Mol Cell. 2002; 10(6):1453-65. DOI: 10.1016/s1097-2765(02)00781-5. View

Hasselblatt P, Gresh L, Kudo H, Guinea-Viniegra J, Wagner E . The role of the transcription factor AP-1 in colitis-associated and beta-catenin-dependent intestinal tumorigenesis in mice. Oncogene. 2008; 27(47):6102-9. DOI: 10.1038/onc.2008.211. View

Kelly K, Siebenlist U . The regulation and expression of c-myc in normal and malignant cells. Annu Rev Immunol. 1986; 4:317-38. DOI: 10.1146/annurev.iy.04.040186.001533. View

Henderson B . Nuclear-cytoplasmic shuttling of APC regulates beta-catenin subcellular localization and turnover. Nat Cell Biol. 2000; 2(9):653-60. DOI: 10.1038/35023605. View

Sancho E, Batlle E, Clevers H . Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol. 2004; 20:695-723. DOI: 10.1146/annurev.cellbio.20.010403.092805. View

10.

Horike S, Cai S, Miyano M, Cheng J, Kohwi-Shigematsu T . Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome. Nat Genet. 2004; 37(1):31-40. DOI: 10.1038/ng1491. View

11.

Mosimann C, Hausmann G, Basler K . Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol. 2009; 10(4):276-86. DOI: 10.1038/nrm2654. View

12.

Sierra J, Yoshida T, Joazeiro C, Jones K . The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev. 2006; 20(5):586-600. PMC: 1410807. DOI: 10.1101/gad.1385806. View

13.

Hallikas O, Palin K, Sinjushina N, Rautiainen R, Partanen J, Ukkonen E . Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding affinity. Cell. 2006; 124(1):47-59. DOI: 10.1016/j.cell.2005.10.042. View

14.

Li J, Wang C . TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis. Nat Cell Biol. 2008; 10(2):160-9. DOI: 10.1038/ncb1684. View

15.

Murphy D, Junttila M, Pouyet L, Karnezis A, Shchors K, Bui D . Distinct thresholds govern Myc's biological output in vivo. Cancer Cell. 2008; 14(6):447-57. PMC: 2723751. DOI: 10.1016/j.ccr.2008.10.018. View

16.

Pomerantz M, Ahmadiyeh N, Jia L, Herman P, Verzi M, Doddapaneni H . The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet. 2009; 41(8):882-4. PMC: 2763485. DOI: 10.1038/ng.403. View

17.

Sansom O, Meniel V, Muncan V, Phesse T, Wilkins J, Reed K . Myc deletion rescues Apc deficiency in the small intestine. Nature. 2007; 446(7136):676-9. DOI: 10.1038/nature05674. View

18.

Major M, Camp N, Berndt J, Yi X, Goldenberg S, Hubbert C . Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. Science. 2007; 316(5827):1043-6. DOI: 10.1126/science/1141515. View

19.

Dekker J . The three 'C' s of chromosome conformation capture: controls, controls, controls. Nat Methods. 2005; 3(1):17-21. DOI: 10.1038/nmeth823. View

20.

Fearon E, Vogelstein B . A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. DOI: 10.1016/0092-8674(90)90186-i. View